Back to List
Genetic and Developmental Disorders

Angelman Syndrome

Angelman Syndrome

China First Rare Disease Catalog item 5

Also known as:Angelman Syndrome

Angelman syndrome is a genetic neurodevelopmental disorder that mainly affects neural development, commonly presenting with developmental delay, limited language ability, motor coordination difficulties, seizures, and sleep problems.

Angelman Syndrome care navigation illustration

Start Here

A quick guide to the next step: which department to start with, what to prepare, and what to ask.

Where to Start

In China, it is recommended to first see pediatrics or pediatric neurology; developmental, motor, and language issues require participation from pediatric rehabilitation; genetic counseling is needed for diagnosis and family risk explanation.

What It Is

Angelman syndrome is mostly related to loss of UBE3A function from the maternal copy of chromosome 15. Children typically present with developmental delay in infancy and early childhood, then show significantly limited language, ataxia, seizures, sleep problems, and characteristic behaviors.

Treatment Available

There is currently no cure; focus is on seizure management, sleep and behavioral support, rehabilitation training, communication aids, feeding, and family caregiving support.

Genetic

Yes, but most cases are not directly inherited from parents. Recurrence risk for future pregnancies varies depending on the genetic mechanism and needs to be explained based on molecular testing results.

Common Delay

Early stages are easily broadly categorized as developmental delay, autism spectrum disorder, or cerebral palsy, without timely consideration of severely limited language, motor coordination, seizures, sleep, and genetic testing clues.

Common Search and Care Questions

Angelman syndrome which doctordevelopmental delay no speech seizuresAngelman syndrome UBE3A testingAngelman syndrome rehabilitationAngelman syndrome recurrence risk

This page helps patients and families organize care leads. It does not replace a clinician’s diagnosis or treatment plan. For testing, medication, referrals, emergency care, and support applications, follow qualified clinicians, medical institutions, support organizations, and official sources.

Diagnosis Path

Organized around the practical patient journey: identify clues, avoid common delays, then prepare for care.

When to Suspect It

  • Obvious developmental delay after 6–12 months — failing to sit, crawl, walk, or develop language.
  • Language expression significantly less than peers, with large gap between comprehension and expression.
  • Unsteady walking, poor motor coordination, hand trembling, or hand-flapping when excited.
  • Repeated seizures, abnormal EEG, or significant sleep problems.
  • Simultaneously presenting microcephaly, feeding difficulties, constipation, easy excitability, or frequent laughter as clues.

Common Wrong Turns

  • Only providing ordinary rehabilitation training without further investigating genetic causes.
  • Being treated as autism or cerebral palsy without evaluating seizures, sleep, and UBE3A-related mechanisms.
  • Only noticing the child 'smiles a lot,' overlooking developmental, language, and motor coordination barriers.
  • Genetic testing results are incomplete, failing to distinguish deletion, uniparental disomy, imprinting errors, or UBE3A variants.

Departments to Start With

  • Pediatrics
  • Pediatric Neurology
  • Pediatric Rehabilitation
  • Genetic Counseling Clinic

Before the Visit

  • Organize developmental milestones, language ability, motor performance, sleep, seizures, and feeding status.
  • Bring EEG, brain imaging, rehabilitation evaluation, genetic testing, and previous diagnosis records.
  • Record developmental delay, seizures, miscarriages, or similar genetic problems in the family.
  • Ask the doctor whether existing testing is sufficient to cover the main genetic mechanisms of Angelman syndrome.

Tests to Ask About

  • 15q11-q13 methylation-related testing.
  • Chromosomal microarray, MLPA, or copy number variation testing.
  • UBE3A gene sequencing or related neurodevelopmental gene testing.
  • EEG and seizure type evaluation.
  • Language, swallowing, motor, cognitive, and sleep assessments.

Questions for the Doctor

  • Which genetic mechanism does the child's test result suggest? How should recurrence risk be assessed?
  • How should seizures, sleep, feeding, and constipation each be managed?
  • Which rehabilitation training and communication aids should be prioritized?
  • Which situations require emergency or prompt follow-up visits?
  • What supportive adjustments can school and home environments provide?

Basic Information

Prevalence
Estimated to occur in approximately 1 in 12,000–20,000 newborns, with variations across different sources and regions.
Category
Genetic and Developmental Disorders
Updated
2026/5/1

Medical Notes

More complete medical explanations are kept here for discussion with clinicians.

Symptoms

Common manifestations include developmental delay, intellectual disability, significantly limited language expression, motor coordination difficulties, unsteady gait, hand-flapping, seizures, sleep disorders, and microcephaly. Some children may also have feeding difficulties, gastroesophageal reflux, constipation, strabismus, or hypopigmentation.

Diagnosis

Diagnosis typically combines developmental and neurological presentations, EEG, developmental assessment, and molecular genetic testing. Methylation testing can detect most cases, but different mechanisms require different testing combinations to explain recurrence risk.

Treatment

Management is primarily long-term support, including seizure treatment, sleep and behavioral management, physical/occupational/speech therapy, augmentative and alternative communication, nutritional and swallowing support. Treatment goals should center on safety, communication, functional participation, and family caregiving sustainability.

Long-term Care

Long-term care needs to focus on seizure control, sleep, constipation, scoliosis, motor ability, communication ability, nutrition, adolescence, and family caregiving stress. Adults still need continuous medical and living support.

Fertility and Family

Recurrence risk for Angelman syndrome depends on the specific genetic mechanism. It is recommended to conduct genetic counseling after confirming the molecular diagnosis to discuss parental testing, recurrence risk for future pregnancies, and options such as prenatal or preimplantation genetic testing.

When to Seek Urgent Care

When seizures are prolonged, consciousness does not recover after repeated episodes, obvious breathing abnormalities, severe dehydration, persistent high fever, or significant mental status changes occur, seek emergency medical attention promptly and bring previous diagnosis and medication information.

Prognosis

Long-term care needs to focus on seizure control, sleep, constipation, scoliosis, motor ability, communication ability, nutrition, adolescence, and family caregiving stress. Adults still need continuous medical and living support.